Nutex Health (NUTX) Financials: Revenue & Earnings

NUTX price $211.75 +3.50 +1.68%

Ticker
NUTX
Price
$211.75
Change
+3.50 +1.68%
Market cap ?
$1.45B
Beta ?
2.00
Sector
Healthcare
Industry
Medical - Care Facilities

Fair value

NUTX fair value $303.63. Price $211.75. Price is 30% below fair value.

Below fair value, but more expensive than usual. A smaller discount than on 67% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 274.17M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 6.85M. Net debt 165.82M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare NUTX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—5.54—214.82M
2026-08-069.384.95210.75M215.03M
2026-04-306.523.99216.49M227.80M
2026-03-051.615.56151.70M258.82M
2025-11-197.761.81267.80M213.81M
2025-10-22-2.95-1.43243.99M244.00M
2025-05-132.563.04211.79M134.24M
2025-03-3111.12-0.12257.62M81.13M
2024-11-08-1.72-0.2478.79M73.22M
2024-08-08-0.07-0.2976.08M68.20M
2024-05-08-0.10—67.45M67.45M
2024-03-28-7.50—69.67M71.40M
2023-11-09-1.50-1.5062.72M66.86M
2023-08-09-1.50-1.5058.92M63.25M
2023-05-15-1.50-3.0056.33M62.05M
2023-03-02-3.00-3.0053.72M49.95M
2022-11-21-3.00—28.40M—
2022-08-22-4.50—58.05M—
2022-05-135.43—79.13M—
2022-04-013.54—63.40M—
2021-11-1513.61—117.97M—
2021-08-166.85—62.81M—
2021-05-24-1.12—2.01M—
2021-04-028.50—106.13M—
2020-11-160.34—350.03K—
2020-08-190.05—378.59K—
2020-06-29-0.27—465.63K—
2019-12-31-1.55—2.15M—
2019-11-19-0.08—17.59K—
2019-08-19-0.10—14.39K—
2019-05-20-0.10—13.53K—
2019-04-16-0.12—37.22K—
2018-11-19-0.08—30.42K—
2018-08-14-0.11—11.62K—
2018-05-15-0.10—12.12K—
2018-04-17-0.94—-593.66K—
2017-11-201.78—26.96K—
2017-08-18-0.56—19.03K—
2012-03-30-0.13—706.18K—
2011-11-10-0.13—601.31K—

Dividends

Yield 0.00%. Payout ratio 28.91%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 29% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-18Saunders Scott JSell203$214.2543.49K
2026-07-31Jaumot Frank EBuy603——
2026-07-31Grenas Cheryl YvonneBuy603——
2026-07-31Saunders Scott JBuy603——
2026-07-31Reed Michael LeeBuy603——
2026-06-04Spears KelvinBuy2.52K——
2026-05-28Vo Thomas T.Buy75.75K——
2026-04-23Reed Michael LeeBuy823——
2026-04-23Saunders Scott JBuy823——
2026-04-23Jaumot Frank EBuy823——
2026-04-23Grenas Cheryl YvonneBuy823——
2026-04-09Vo Thomas T.Buy184.07K——
2026-03-20Jaumot Frank EBuy150$93.5614.03K
2026-03-19Hosseinion WarrenBuy252$94.0723.71K
2026-03-17Spears KelvinBuy10$94.46945
2026-03-13Montgomery Pamela W.Buy79$88.877.02K
2026-03-11Bamburg Wesley ShaneBuy2.41K——
2026-03-11Bates Jon ChristianBuy1.69K——
2026-03-10Vo Thomas T.Buy4.84K——
2026-03-10Hosseinion WarrenBuy3.66K——
2026-03-10Spears KelvinBuy116——
2026-03-10Montgomery Pamela W.Buy1.52K——
2026-03-10Luqman Elisa VBuy1.52K——
2026-03-10Luqman Elisa VBuy2.08K——
2026-03-10Luqman Elisa VSell784$86.2267.60K
2026-03-10Montgomery Pamela W.Buy1.52K——
2026-03-10Montgomery Pamela W.Buy2.08K——
2026-03-10Montgomery Pamela W.Sell776$86.2266.91K
2026-03-10Spears KelvinBuy183——
2026-03-10Spears KelvinSell82$86.227.07K
2026-03-10Spears KelvinBuy116——
2026-03-10Chang Michael L.Buy2.08K——
2026-03-10Chang Michael L.Sell769$86.2266.31K
2026-03-10Chang Michael L.Buy1.94K——
2026-03-10Hosseinion WarrenBuy3.66K——
2026-03-10Hosseinion WarrenBuy6.29K——
2026-03-10Hosseinion WarrenSell3.27K$86.22282.29K
2026-03-10Vo Thomas T.Buy8.33K——
2026-03-10Vo Thomas T.Sell3.02K$86.22260.13K
2026-03-10Vo Thomas T.Buy4.84K——
2026-03-10Bates Jon ChristianBuy2.67K——
2025-11-25Bates Jon ChristianBuy750$136.71102.53K
2025-10-15Bamburg Wesley ShaneOther0——
2025-07-14Saunders Scott JBuy603——
2025-07-14Reed Michael LeeBuy603——
2025-07-14Grenas Cheryl YvonneBuy603——
2025-07-14Jaumot Frank EBuy603——
2025-07-14Jaumot Frank EOther0——
2025-04-08Bates Jon ChristianBuy1.00K$81.8181.81K
2025-04-04Spears KelvinSell34$72.102.45K
2025-04-04DeTillio JoshuaSell452$72.1032.59K
2025-04-04Montgomery Pamela W.Sell266$72.1019.18K
2025-04-04Montgomery Pamela W.Sell24$72.101.73K
2025-04-04Chang Michael L.Sell266$72.1019.18K
2025-04-04Vo Thomas T.Buy895$72.1064.53K
2025-04-04Hosseinion WarrenSell1.07K$72.1077.29K
2025-04-04Luqman Elisa VSell266$72.1019.18K
2025-03-10Bates Jon ChristianBuy3.50K——
2025-03-10Spears KelvinBuy120——
2025-03-10Montgomery Pamela W.Buy2.50K——
2025-03-10Chang Michael L.Buy2.50K——
2025-03-10Vo Thomas T.Buy10.00K——
2025-03-10Hosseinion WarrenBuy7.55K——
2025-03-10Luqman Elisa VBuy2.50K——
2025-03-01Bates Jon ChristianBuy1.50K——
2025-03-01Bates Jon ChristianBuy111——
2025-03-01Spears KelvinBuy143——
2025-03-01DeTillio JoshuaBuy5.95K——
2025-03-01DeTillio JoshuaBuy2.12K——
2025-03-01Montgomery Pamela W.Buy1.25K——
2025-03-01Montgomery Pamela W.Buy111——
2025-03-01Chang Michael L.Buy1.25K——
2025-03-01Vo Thomas T.Buy5.00K——
2025-03-01Hosseinion WarrenBuy3.78K——
2025-03-01Luqman Elisa VBuy1.25K——
2025-01-08Vo Thomas T.Buy5.00K——
2024-08-22Bates Jon ChristianBuy1.35K$21.4628.97K
2024-08-20DeTillio JoshuaBuy575$17.4010.01K
2024-08-19DeTillio JoshuaBuy1.30K$17.8523.21K
2024-07-12Vo Thomas T.Buy22.71K——
2024-06-28Luqman Elisa VBuy37.50K——
2024-06-28Montgomery Pamela W.Buy37.50K——
2024-06-28Chang Michael L.Buy37.50K——
2024-06-28DeTillio JoshuaBuy63.75K——
2024-06-28Bates Jon ChristianBuy45.00K——
2024-06-28Hosseinion WarrenBuy113.27K——
2024-06-28Vo Thomas T.Buy150.00K——
2024-06-12DeTillio JoshuaBuy20.00K$0.5410.80K
2024-05-30Vo Thomas T.Buy2.99K$0.661.97K
2024-05-29Vo Thomas T.Buy3.77K$0.682.56K
2024-05-28Vo Thomas T.Buy48.39K$0.7033.88K
2024-05-13Vo Thomas T.Buy17.33K$0.6911.96K
2024-04-11Saunders Scott JOther0——
2024-03-12Bates Jon ChristianBuy49.51K$0.0050
2024-03-12Bates Jon ChristianSell49.51K——
2024-03-12Montgomery Pamela W.Buy16.50K——
2024-03-12Montgomery Pamela W.Sell16.50K——
2024-02-28Spears KelvinSell0——
2023-11-20Vo Thomas T.Buy275.20K$0.2362.20K
2023-11-17Vo Thomas T.Buy224.80K$0.2351.70K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 156, holders +26 vs prior quarter. Ownership 43.00%.

HolderSharesChangeChange %Value
PERTENTO PARTNERS LLP451.31K77.34K+20.68%77.12M
BLACKROCK, INC.407.35K27.99K+7.38%69.61M
AMERICAN CENTURY COMPANIES INC237.41K33.96K+16.69%40.57M
VANGUARD CAPITAL MANAGEMENT LLC215.92K-3.21K-1.47%36.90M
GEODE CAPITAL MANAGEMENT, LLC132.05K9.94K+8.14%22.57M
STATE STREET CORP130.84K7.66K+6.22%22.36M
D. E. SHAW & CO., INC.97.45K97.45KNew16.65M
UBS GROUP AG77.91K8.34K+11.99%13.31M
WINMILL & CO. INC65.35K00.00%11.17M
FOCUS PARTNERS WEALTH60.88K60.88KNew10.40M
MILLENNIUM MANAGEMENT LLC52.11K-37.46K-41.83%8.90M
GOLDMAN SACHS GROUP INC51.24K17.45K+51.63%8.76M
BRIDGEWAY CAPITAL MANAGEMENT, LLC46.92K31.90K+212.41%8.02M
EMPOWERED FUNDS, LLC45.18K12.73K+39.22%7.72M
PACER ADVISORS, INC.44.61K15.94K+55.58%7.62M
NORTHERN TRUST CORP44.06K2.79K+6.76%7.53M
TOPLINE CAPITAL MANAGEMENT, LLC41.76K-136.04K-76.51%7.14M
ONE PLUS ONE WEALTH MANAGEMENT, LLC40.44K00.00%6.91M
VANGUARD FIDUCIARY TRUST CO35.97K141+0.39%6.15M
VANGUARD PORTFOLIO MANAGEMENT LLC34.66K-5.14K-12.92%5.92M
VICTORY CAPITAL MANAGEMENT INC29.19K-15.94K-35.33%4.99M
TRUIST FINANCIAL CORP26.81K492+1.87%4.58M
LOS ANGELES CAPITAL MANAGEMENT LLC25.15K-6.91K-21.55%4.30M
BANK OF NEW YORK MELLON CORP23.15K1.53K+7.07%3.96M
BARCLAYS PLC22.48K4.60K+25.71%3.84M

Earnings and financials

Nutex Health, Inc. (NUTX) trades at $211.75, with a market cap of $1.45B and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Nutex Health (NUTX) Financials: Revenue & Earnings

NUTX$211.75+3.50 +1.68%

$1.45B

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History